相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of Capecitabine Maintenance Therapy Using Lower Dosage and Higher Frequency vs Observation on Disease-Free Survival Among Patients With Early-Stage Triple-Negative Breast Cancer Who Had Received Standard Treatment The SYSUCC-001 Randomized Clinical Trial
Xi Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
MiR-421 promotes the development of osteosarcoma by regulating MCPIP1 expression
Zhaozhou Ren et al.
CANCER BIOLOGY & THERAPY (2020)
Identification of candidate genes and miRNAs for sensitizing resistant colorectal cancer cells to oxaliplatin and irinotecan
Mansour Poorebrahim et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2020)
MCPIP1 overexpression in human neuroblastoma cell lines causes cell-cycle arrest by G1/S checkpoint block
Elzbieta Boratyn et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p/ZNF703
Xu Gang et al.
CANCER CELL INTERNATIONAL (2020)
HSulf-1 and palbociclib exert synergistic antitumor effects on RB-positive triple-negative breast cancer
Fengxia Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2020)
Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial
Junjie Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process
Huiqing Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2020)
ECRG4 Represses Cell Proliferation and Invasiveness via NFIC/OGN/NF-κB Signaling Pathway in Bladder Cancer
Xin Liang et al.
FRONTIERS IN GENETICS (2020)
VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop
Asma Boudria et al.
ONCOGENE (2019)
CD44 splice isoform switching determines breast cancer stem cell state
Honghong Zhang et al.
GENES & DEVELOPMENT (2019)
Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway
Tianqi Li et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
Alice Lee et al.
CANCER TREATMENT REVIEWS (2018)
Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+breast cancer cell proliferation and stem cell survival
Andrew Baker et al.
ONCOGENE (2018)
RANK-c attenuates aggressive properties of ER-negative breast cancer by inhibiting NF-κB activation and EGFR signaling
Chaido Sirinian et al.
ONCOGENE (2018)
Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3
Hao Ke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Single-Cell Mobility Analysis of Metastatic Breast Cancer Cells
Jialang Zhuang et al.
ADVANCED SCIENCE (2018)
Metastatic triple negative breast cancer: Optimizing treatment options, new and emerging targeted therapies
Parham Khosravi-Shahi et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2018)
TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing
Tieju Liu et al.
MOLECULAR CANCER THERAPEUTICS (2017)
MCPIP1 Downregulation in Clear Cell Renal Cell Carcinoma Promotes Vascularization and Metastatic Progression
Paulina Marona et al.
CANCER RESEARCH (2017)
CELF1 preferentially binds to exon-intron boundary and regulates alternative splicing in HeLa cells
Heng Xia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes
A. Sveen et al.
ONCOGENE (2016)
MCPIP1 Selectively Destabilizes Transcripts Associated with an Antiapoptotic Gene Expression Program in Breast Cancer Cells That Can Elicit Complete Tumor Regression
Wenbao Lu et al.
CANCER RESEARCH (2016)
Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment
Guowei Gu et al.
CURRENT OPINION IN PHARMACOLOGY (2016)
Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Jun Chen et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Treating cancer with selective CDK4/6 inhibitors
Ben O'Leary et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
The ErbB2ΔEx16 splice variant is a major oncogenic driver in breast cancer that promotes a pro-metastatic tumor microenvironment
J. Turpin et al.
ONCOGENE (2016)
Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer
Hye-Kyung Lee et al.
BMC CANCER (2015)
CLK2 Is an Oncogenic Kinase and Splicing Regulator in Breast Cancer
Taku Yoshida et al.
CANCER RESEARCH (2015)
SRSF1-Regulated Alternative Splicing in Breast Cancer
Olga Anczukow et al.
MOLECULAR CELL (2015)
Deregulation of splicing factors and breast cancer development
Marco Silipo et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2015)
Hallmarks of alternative splicing in cancer
S. Oltean et al.
ONCOGENE (2014)
Clinicopathological features of breast cancer with different molecular subtypes in chinese women
Hong-tao Cheng et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2013)
MCPIP1 ribonuclease exhibits broad-spectrum antiviral effects through viral RNA binding and degradation
Ren-Jye Lin et al.
NUCLEIC ACIDS RESEARCH (2013)
Locoregional treatments for triple-negative breast cancer
W. Eiermann et al.
ANNALS OF ONCOLOGY (2012)
Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) is a novel multifunctional modulator of inflammatory reactions
Jolanta Jura et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial
Adam Brufsky et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
MCPIP1 Ribonuclease Antagonizes Dicer and Terminates MicroRNA Biogenesis through Precursor MicroRNA Degradation
Hiroshi I. Suzuki et al.
MOLECULAR CELL (2011)
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
Poulikos I. Poulikakos et al.
NATURE (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
Anti-tumor activity of splice-switching oligonucleotides
John A. Bauman et al.
NUCLEIC ACIDS RESEARCH (2010)
Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay
Kazufumi Matsushita et al.
NATURE (2009)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer
Jerome Eeckhoute et al.
GENES & DEVELOPMENT (2006)
The connection between splicing and cancer
Anabella Srebrow et al.
JOURNAL OF CELL SCIENCE (2006)
Monocyte chemoattractant protein-1 induces a novel transcription factor that causes cardiac myocyte apoptosis and ventricular dysfunction
Limei Zhou et al.
CIRCULATION RESEARCH (2006)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Roles of the NFI/CTF gene family in transcription and development
RM Gronostajski
GENE (2000)
分享论文
